Baker McKenzie has the pleasure of inviting you to an afternoon of conversations on themes ranging from discovery, AI and innovation, EU joint procurement…
- EHDS Deep-Dive: EHR systems, wellness apps and medical devices (Part 4)
- ECJ Ruling: Pharma Payments to State Health Insurers Are Rebates, Not Taxes
- EHDS Deep-Dive: New pathway for accessing health data (Part 3)
- EHDS Deep-Dive: New pathway for accessing health data (Part 2)
- European Health Data Space Deep-Dive: Health data rights (Part 1)
- Invitation: Accelerating Innovation with AI, a Chat with HERA and Latest Trends in Life Science Dealmaking
- EU AI Act Published: Dates for Action
- Guest Feature: India Pharma Focus – 4 Key Industry Developments to Track
In Brief The long-awaited EU AI Act was published in the Official Journal of the European Union today, 12 July 2024. The Act regulates…
The Indian pharmaceutical sector is currently undergoing significant regulatory changes. All stakeholders, including Indian companies, prospective investors, pharma retailers and HCPs should be closely…
Today the European Commission has finally published its Proposal to revise the EU Pharmaceutical legislation, the most momentous…
On 26 April 2023 the European Commission published its Proposals to Reform the EU pharmaceutical legislation.[1] We continue…
In brief Reimbursing medicinal products is critical to ensure that treatments are widely available to patients. This is…
The Proposal to revise the EU Pharmaceutical legislation has generated unprecedented levels of attention, not only across the…
As previously covered in this blog, on 26 April 2023 the European Commission published a set of proposals…
As already well noted on this blog, on 26 April 2023 the European Commission published a set of…